Correlation Between Lyxor 1 and CREO MEDICAL

Can any of the company-specific risk be diversified away by investing in both Lyxor 1 and CREO MEDICAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyxor 1 and CREO MEDICAL into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyxor 1 and CREO MEDICAL GRP, you can compare the effects of market volatilities on Lyxor 1 and CREO MEDICAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyxor 1 with a short position of CREO MEDICAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyxor 1 and CREO MEDICAL.

Diversification Opportunities for Lyxor 1 and CREO MEDICAL

-0.37

Correlation Coefficient

Lyxor 1  CREO MEDICAL

Very good diversification

The 3 months correlation between Lyxor and CREO is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Lyxor 1 and CREO MEDICAL GRP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CREO MEDICAL GRP and Lyxor 1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyxor 1 are associated (or correlated) with CREO MEDICAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CREO MEDICAL GRP has no effect on the direction of Lyxor 1 i.e., Lyxor 1 and CREO MEDICAL go up and down completely randomly.

Pair Corralation between Lyxor 1 and CREO MEDICAL

Assuming the 90 days trading horizon Lyxor 1 is expected to generate 0.24 times more return on investment than CREO MEDICAL. However, Lyxor 1 is 4.23 times less risky than CREO MEDICAL. It trades about 0.2 of its potential returns per unit of risk. CREO MEDICAL GRP is currently generating about -0.16 per unit of risk. If you would invest  2,485  in Lyxor 1 on December 20, 2024 and sell it today you would earn a total of  295.00  from holding Lyxor 1 or generate 11.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lyxor 1   vs.  CREO MEDICAL GRP

Lyxor 1

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Lyxor 1 are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Lyxor 1 may actually be approaching a critical reversion point that can send shares even higher in April 2025.

CREO MEDICAL GRP

Risk-Adjusted Performance

Very Weak

Over the last 90 days CREO MEDICAL GRP has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Lyxor 1 and CREO MEDICAL

The main advantage of trading using opposite Lyxor 1 and CREO MEDICAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyxor 1 position performs unexpectedly, CREO MEDICAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CREO MEDICAL will offset losses from the drop in CREO MEDICAL's long position.

The idea behind Lyxor 1 and CREO MEDICAL GRP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.